Serena Williams faces backlash over Super Bowl ad promoting weight-loss drugs

A recent Super Bowl commercial featuring tennis legend Serena Williams has sparked a significant debate regarding the ethical implications of celebrity endorsements for prescription weight-loss medications. 

In the advertisement for the telehealth platform Ro, Williams shares her personal journey of losing over 30 pounds using GLP-1 treatments after struggling with post-pregnancy weight. 

Critics argue that featuring a global



sports icon in pharmaceutical marketing blurs the line between medical necessity and lifestyle promotion, potentially oversimplifying complex clinical treatments. 

The controversy is further intensified by the fact that Williams' husband, Alexis Ohanian, serves as a board member for the company. Medical experts and social media users have raised concerns about the impact of such high-profile endorsements on public health and the risks of self-prescription.